The forecast for liver malignant neoplasms mortality among women in the UK shows a stable trend from 2024 through 2028, with the mortality rate maintaining at 6.2 deaths per hundred thousand women from 2025 onward. Compared to the 2023 data, this indicates slight growth, but the increments stabilize after 2025. No significant year-on-year variations suggest a plateau in mortality rates over this period. The compound annual growth rate (CAGR) is effectively zero, indicating consistent rates with minimal yearly change.
Future trends to watch for include advancements in medical treatment, early detection technologies, and public health initiatives aimed at reducing risk factors such as alcohol consumption and obesity. Changes in these areas could potentially influence mortality rates beyond 2028, either reducing them significantly with successful interventions or increasing if current challenges remain unaddressed.
